Baker Bros. Advisors LP 13D and 13G filings for Talis Biomedical Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-10 4:55 pm Purchase |
2023-03-10 | 13D | Talis Biomedical Corporation TLIS |
Baker Bros. Advisors LP | 2,505,086 66.200% |
4,750 (+0.19%) |
Filing |
| 2022-06-13 5:27 pm Purchase |
2022-06-07 | 13D | Talis Biomedical Corporation TLIS |
Baker Bros. Advisors LP | 2,500,336 66.400% |
4,389 (+0.18%) |
Filing |
| 2021-04-02 4:01 pm Unchanged |
2021-03-26 | 13D | Talis Biomedical Corporation TLIS |
Baker Bros. Advisors LP | 2,495,947 67.500% |
0 (Unchanged) |
Filing |
| 2021-02-26 4:52 pm Purchase |
2021-02-17 | 13D | Talis Biomedical Corporation TLIS |
Baker Bros. Advisors LP | 2,495,947 67.600% |
2,495,947 (New Position) |
Filing |